Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (101-110 of 460) with videos related to

Pageof 46
Sort By:
Nature Nanotechnology|January 13, 2021
Nanomaterials for T-cell cancer immunotherapyNingqiang Gong, Neil C Sheppard, Margaret M Billingsley, et al.
Nature|July 26, 2023
CAR T therapy beyond cancer: the evolution of a living drugDaniel J Baker, Zoltan Arany, Joseph A Baur, et al.
Journal of Virology|October 12, 2007
Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cellsGabriela Plesa, Jihong Dai, Cliff Baytop, et al.
Annual Review of Medicine|November 27, 2013
Chimeric antigen receptor therapy for cancerDavid M Barrett, Nathan Singh, David L Porter, et al.
Science (New York, N.Y.)|March 24, 2018
CAR T cell immunotherapy for human cancerCarl H June, Roddy S O'Connor, Omkar U Kawalekar, et al.
Geroscience|August 7, 2025
The senescence-inhibitory p53 isoform Δ133p53α: enhancing cancer immunotherapy and exploring novel therapeutic approaches for senescence-associated diseasesShinji Nakamichi, Leo Yamada, Christopher Roselle, et al.
Glycobiology|January 26, 2018
Glycan-directed CAR-T cellsCatharina Steentoft, Denis Migliorini, Tiffany R King, et al.
Nature Medicine|April 22, 2003
Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cellsMathias Oelke, Marcela V Maus, Dominic Didiano, et al.
Nano Letters|January 18, 2020
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell EngineeringMargaret M Billingsley, Nathan Singh, Pranali Ravikumar, et al.
ACS Synthetic Biology|December 6, 2024
Stem Loop Mediated Transgene Modulation in Human T CellsDavid Mai, Carly Harro, Aabir Sanyal, et al.
Pageof 46

Showing results (101-110 of 460) with videos related to

Sort By:
Pageof 46
Nature Nanotechnology|January 13, 2021
Nanomaterials for T-cell cancer immunotherapyNingqiang Gong, Neil C Sheppard, Margaret M Billingsley, et al.
Nature|July 26, 2023
CAR T therapy beyond cancer: the evolution of a living drugDaniel J Baker, Zoltan Arany, Joseph A Baur, et al.
Journal of Virology|October 12, 2007
Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cellsGabriela Plesa, Jihong Dai, Cliff Baytop, et al.
Annual Review of Medicine|November 27, 2013
Chimeric antigen receptor therapy for cancerDavid M Barrett, Nathan Singh, David L Porter, et al.
Science (New York, N.Y.)|March 24, 2018
CAR T cell immunotherapy for human cancerCarl H June, Roddy S O'Connor, Omkar U Kawalekar, et al.
Geroscience|August 7, 2025
The senescence-inhibitory p53 isoform Δ133p53α: enhancing cancer immunotherapy and exploring novel therapeutic approaches for senescence-associated diseasesShinji Nakamichi, Leo Yamada, Christopher Roselle, et al.
Glycobiology|January 26, 2018
Glycan-directed CAR-T cellsCatharina Steentoft, Denis Migliorini, Tiffany R King, et al.
Nature Medicine|April 22, 2003
Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cellsMathias Oelke, Marcela V Maus, Dominic Didiano, et al.
Nano Letters|January 18, 2020
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell EngineeringMargaret M Billingsley, Nathan Singh, Pranali Ravikumar, et al.
ACS Synthetic Biology|December 6, 2024
Stem Loop Mediated Transgene Modulation in Human T CellsDavid Mai, Carly Harro, Aabir Sanyal, et al.
Pageof 46